08:00 | Registration |
| Session: Data Analysis and Bioinformatics | Session Sponsors |
| |
09:30 | A Comparison of Both De Novo and Transcriptome Analysis for Exploring the Diversity within the Gene Pool Guy Barker, Director, University of Warwick, United Kingdom
Transcriptome sequencing across gene pools can provide answers to a number of questions. The application to a systems approach for pathway analysis will be shown. |
10:00 | Can we Exploit the Power of NGS to Move Towards Personalized Medicine? Elia Stupka, Co-Director/Head, San Raffaele Scientific Institute, Italy
NGS is becoming common place in a clinical environment. Generating data, however, is only the tip of the iceberg. A talk on successes, failures and challenges ahead, if we want to turn NGS into the holy grail of "personalized medicine''. |
10:30 | Coffee Break and Networking in Exhibition Hall |
11:15 | CRAM: A Framework for Sequence Data Compression Guy Cochrane, Team Leader, European Bioinformatics Institute, United Kingdom
In the talk, I will detail the needs for compression of raw NGS data and will describe the CRAM concept for serving these needs. Finally, I will outline approaches that apply compression differentially across the growing body of NGS data. |
| Session: Sequencing Platforms and Methods |
| |
11:45 | The Ion Torrent Personal Genome Machine at Kingston University, London Lori Snyder, Reader, Kingston University, United Kingdom
The Ion Torrent Personal Genome Machine is an affordable platform, which has enabled researchers and educators at Kingston University to access cutting edge NGS technology. |
12:15 | Technology Spotlight: Optimising Efficiency in a High-throughput Service Lab – Automation Solutions Niels Kruize, Sales Director, LGC Genomics
Running a high-throughput genotyping and nucleic acid preparation service laboratory provides our instrumentation development team with a unique insight to the challenges faced by our customers in their own operations. The development of the LGC Genomics/KBioscience range of laboratory instrumentation has always been driven by innovations required to improve efficiency in our own laboratories and the presentation at this year’s ELA focuses on some of the key developments we have initiated in the areas of high-throughput MTP replication, DNA extraction, assay dispensing and liquid handling and high throughput water bath thermal cycling for PCR. The presentation includes videos, animations and graphical representations of our laboratory automation solutions, their development and overviews of the workflow solutions we have developed to optimise throughput in singleplex genotyping projects and the flexibility offered through this approach to data set generation. |
12:30 | Lunch and Networking in Exhibition Hall |
13:30 | Poster Viewing Session |
14:15 | Ion Torrent PGM Sequencer in Genomic and Transcriptomic Analysis Marzanna Gontarczyk, , University of Zurich, Switzerland
The Ion Torrent PGM semiconductor-based platform is the first commercially available non-optical sequencing technology. Some of the sequencing applications in genome and transcriptome analysis are presented. |
14:45 | Technologies Development for High-throughput Immune Sequencing Francois Vigneault, Post doctoral Fellow, Harvard Medical School, United States of America
We discuss the technology of Immune Sequencing and applications as well as future developments. |
15:15 | Coffee Break and Networking in Exhibition Hall |
16:00 | Integration of Next Gen Sequencing in a Genomics Core Patrick Descombes, Head, Nestle Institute of Health Sciences, Switzerland
The presentation will address the revolution introduced by NGS technologies, its complementarities to other genomics technologies, and some of the consequences for Core labs, such as the need to implement LIMS and robotics. |
16:30 | Insights in shRNA Processing and siRNA Mode of Action Using Next Generation Sequencing Sterghios Moschos, Director, University of Westminster, United Kingdom
This talk will discuss a new application of NGS in proving the mode of action and relative activity of RNAi therapeutics. Opportunities in companion diagnostic development will be presented alongside novel data on the processsivity and precision of key enzymes involved in RNAi. |
17:00 | Drinks Reception |